TAYLOR CLARK: Open Payments
NPI 1952008351 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 32 payments from 11 companies in 2025. Trend: 2023 $470 · 2024 $461 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 12 | $98 |
| Sage Therapeutics, LLC | 4 | $94 |
| ABBVIE INC. | 4 | $85 |
| SHIELD THERAPEUTICS INC | 3 | $59 |
| MILLICENT US INC | 2 | $42 |
| Organon LLC | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $13 |
Products named: ZURZUVAE, ACCRUFER, VRAYLAR, NEXPLANON, INTRAROSA, INJECTAFER, FEMRING, Wegovy.
Industry payments across SC — which companies pay providers there.
